Medical/Pharmaceuticals

Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata

SHANGHAI, June 18, 2020 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced dosing of the first patient in their Phase II, global clinical trial (R...

2020-06-19 09:16 1245

Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI, June 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company focused on the discovery and development of next-generation of immunomodulatory small molecules for the treatments of solid tumors, hematological malignancies, auto-immune diseases as well as inflammatory...

2020-06-17 21:00 1641

Immunexpress Awarded BARDA Contract to Develop SeptiCyte® RAPID for COVID-19 Patient Triage

SEATTLE, June 16, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, has been awarded a grant from the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary ...

2020-06-16 20:00 1043

Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat® Research

PORTSMOUTH, New Hampshire and LAUSANNE, Switzerland, June 15, 2020 /PRNewswire/ -- Epredia , a global leader in precision cancer diagnostics and tissue diagnostics, and Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment f...

2020-06-15 20:00 1655

I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II

SHANGHAI and GAITHERSBURG, Md., June 12, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, will be presenting preclinical data on a newly developed, novel asset TJ...

2020-06-12 20:00 7086

World's first iLDC enabling ADC drug receives IND clearance by the US FDA

SUZHOU, China, June 11, 2020 /PRNewswire/ -- GeneQuantum Healthcare (GQ) has recently received the US IND approval for its in-house developed next generation antibody drug conjugate (ADC) asset, GQ1001. This isthe world's first site-specific ADC produced using the intelligent ligase-dependent co...

2020-06-11 17:10 1169

Sao Thai Duong JSC launches RT-LAMP KIT to Meet Demands for the Widening of Testing After Easing of Lockdown

HANOI, Vietnam, June 10, 2020 /PRNewswire/ -- Governments around the world have achieved various levels of success in using lockdown and social distancing to stop the spread of the Coronavirus within the community and to deal with the COVID-19 pandemic.According epidemiologists, the easing of a l...

2020-06-11 10:01 1711

PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I

DAEJEON, South Korea, June 10, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer. Under this agreement, PharmA...

2020-06-11 00:00 946

CellResearch Corporation - Source of cGMP Umbilical Cord Lining Stem Cells for COVID-19 Related Investigator Initiated Clinical Trials

SINGAPORE, June 10, 2020 /PRNewswire/ -- CellResearch Corporation (CellResearch), a regenerative medicine biotechnology company, is making its cGMP-grade umbilical cord lining stem cell product, CorLiCyte®, available complimentary to any licensed medical institution that is seeking to initiat...

2020-06-10 21:00 1086

Sichuan University, Oxford University launch joint cancer research center

CHENGDU, China, June 10, 2020 /PRNewswire/ -- The University of Oxford and China's Sichuan University have jointly launched a center to bolster research cooperation on gastrointestinal cancer. Representatives from the two sides signed a contract for the Sichuan University-University of Oxford Hu...

2020-06-10 17:29 953

China Eastern Airlines: 200+ Medical Supply Flights to Europe

SHANGHAI, June 10, 2020 /PRNewswire/ -- At 09:09 AM June 5 local time, a China Eastern Airlines (CEA) "passenger to cargo" flight MU7263 took off fromJinan to Milan fully loaded with over 20 tons of supplies. This is CEA's 22nd flight transporting medical equipment directly fromChina to Italy. ...

2020-06-10 14:39 2362

Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody

SUZHOU, China, June 9, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur ofShanghai, Chinese Academy of...

2020-06-10 08:40 5923

Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi (EURONEXT: SAN and NASDAQ: SNY), a global biopharmaceutical leader, announced today that Jiangsu Alpham...

2020-06-09 10:10 5827

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announ...

2020-06-09 07:30 1834

Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer

SHANGHAI and HONG KONG, June 8, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced its appointment of Mr.Donald Lung as Chief Financial Officer (CFO), effectiveJune 8, 2020. Donald will report directly to Dr.Jay Mei, Chairman and CEO of Antengene.

2020-06-08 20:00 2237

Healios Successfully Establishes Proprietary Universal Donor Cell Research Line

TOKYO, June 5, 2020 /PRNewswire/ -- Healios K.K. (hereinafter "the Company"; TSE: 4593),Japan's leading clinical-stage biotechnology company, has been creating Universal Donor Cells (UDCs), which are next-generation iPS cells created with gene-editing technology to engineer a low risk of immune r...

2020-06-05 13:00 2158

China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering

HANGZHOU, China, June 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it clos...

2020-06-04 04:00 12334

CAREMILLE INT. Launches PPE, Pro Guard and Pro Guard S1 & S2 for Medical Professionals to Help Battle Against the COVID-19 Pandemic

SEOUL, South Korea, June 3, 2020 /PRNewswire/ -- Even in the global pandemic situation,South Korea's successful response and protocol to COVID-19 is highly regarded, and interest in Korean disinfection and protection products is increasing significantly.

2020-06-03 21:20 2358

Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE™ for the Treatment of Neuroblastoma

SYDNEY, June 3, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to67Cu-SARTATE™, a therapy for th...

2020-06-03 21:08 1369

Olsztyn's Chinese sister city Weifang shares anti-epidemic tips as bilateral ties get closer amid COVID-19

WEIFANG, China, June 3, 2020 /PRNewswire/ -- According to the Foreign Affairs Office of Weifang Municipal Government, a video conference was held onMay 26 among participants fromWarsaw, Olsztyn and two Chinese cities Jinan and Weifang in eastChina's Shandong Province. Olsztyn and Weifang, as sist...

2020-06-03 16:43 1275
1 ... 199200201202203204205 ... 214